| Literature DB >> 34222252 |
Wanyun Zhang1, Zhijun Chen1, Han Zhang2, Guannan Su1, Rui Chang1, Lin Chen1, Ying Zhu1, Qingfeng Cao1, Chunjiang Zhou1, Yao Wang1, Peizeng Yang1.
Abstract
Fuchs' uveitis syndrome (FUS) is one of the most under- or misdiagnosed uveitis entities. Many undiagnosed FUS patients are unnecessarily overtreated with anti-inflammatory drugs, which may lead to serious complications. To offer assistance for ophthalmologists in the screening and diagnosis of FUS, we developed seven deep convolutional neural networks (DCNNs) to detect FUS using slit-lamp images. We also proposed a new optimized model with a mixed "attention" module to improve test accuracy. In the same independent set, we compared the performance between these DCNNs and ophthalmologists in detecting FUS. Seven different network models, including Xception, Resnet50, SE-Resnet50, ResNext50, SE-ResNext50, ST-ResNext50, and SET-ResNext50, were used to predict FUS automatically with the area under the receiver operating characteristic curves (AUCs) that ranged from 0.951 to 0.977. Our proposed SET-ResNext50 model (accuracy = 0.930; Precision = 0.918; Recall = 0.923; F1 measure = 0.920) with an AUC of 0.977 consistently outperformed the other networks and outperformed general ophthalmologists by a large margin. Heat-map visualizations of the SET-ResNext50 were provided to identify the target areas in the slit-lamp images. In conclusion, we confirmed that a trained classification method based on DCNNs achieved high effectiveness in distinguishing FUS from other forms of anterior uveitis. The performance of the DCNNs was better than that of general ophthalmologists and could be of value in the diagnosis of FUS.Entities:
Keywords: Fuchs’ uveitis syndrome; deep convolutional neural model; deep learning; diffuse iris depigmentation; slit-lamp images
Year: 2021 PMID: 34222252 PMCID: PMC8250145 DOI: 10.3389/fcell.2021.684522
Source DB: PubMed Journal: Front Cell Dev Biol ISSN: 2296-634X
Uveitis entities in the Non-Fuchs’ uveitis syndrome group.
| Entity | Total | Number (%) | |
| The training and validation set | The test set | ||
| Idiopathic chronic anterior uveitis | 124 | 100 (26.2) | 24 (26.1) |
| Posner–Schlossman syndrome | 83 | 66 (17.3) | 17 (18.5) |
| Presumed viral anterior uveitis | 74 | 60 (15.7) | 14 (15.2) |
| Acute anterior uveitis | 66 | 53 (13.9) | 13 (14.1) |
| Sarcoidosis | 62 | 51 (13.3) | 11 (12.0) |
| Vogt–Koyanagi–Harada disease | 35 | 28 (7.3) | 7 (7.6) |
| Behcet’s disease | 30 | 24 (6.3) | 6 (6.5) |
| Total | 474 | 382 | 92 |
FIGURE 1The architecture of SET-ResNext50. We used ResNext50 as backend uniting a mixed “attention” module (the Squeeze-and-Excitation module and the Spatial Transform module). This network was pre-trained in a classification dataset Imagenet to initialize its parameters. Then, we modified the last layer to output a two-dimension vector and updated all the parameters by using the cross entropy.
Performance of the deep convolutional neural networks with fivefold cross-validation and the compared methods in the test set.
| Accuracy (SD) | Precision (SD) | Recall (SD) | F1-measure (SD) | |||
| The classical DCNNs | Xception | 0.883 (0.007) | 0.861 (0.039) | 0.875 (0.047) | 0.866 (0.008) | <0.01 |
| Resnet50 | 0.903 (0.016) | 0.879 (0.047) | 0.905 (0.044) | 0.890 (0.016) | 0.044 | |
| SE-Resnet50 | 0.893 (0.025) | 0.855 (0.040) | 0.909 (0.052) | 0.880 (0.028) | 0.007 | |
| ResNext50 | 0.904 (0.015) | 0.889 (0.019) | 0.890 (0.048) | 0.889 (0.020) | 0.052 | |
| SE-ResNext50 | 0.893 (0.024) | 0.897 (0.038) | 0.852 (0.045) | 0.873 (0.029) | <0.01 | |
| Ablation experiments | ST-ResNext50 | 0.896 (0.013) | 0.885 (0.036) | 0.879 (0.068) | 0.880 (0.021) | 0.014 |
| Our proposed model | SET-ResNext50 | 0.930 (0.005) | 0.918 (0.028) | 0.923 (0.027) | 0.920 (0.004) | − |
| Ophthalmologists | Resident | 0.597 (0.045) | 0.539 (0.054) | 0.638 (0.095) | 0.578 (0.009) | <0.01 |
| Attending | 0.709 (0.032) | 0.648 (0.018) | 0.722 (0.100) | 0.681 (0.056) | <0.01 |
FIGURE 2Receiver operating characteristic curves of the performance for diagnosis of Fuchs uveitis syndrome in the test set. SET-ResNext50 achieved an AUC of 0.977 (95%CI, 0.975–0.979), which outperformed other developed networks and outperformed all the ophthalmologists by a large margin.
FIGURE 3The heat maps of the SET-ResNext50 model in slit-lamp image with Fuchs uveitis syndrome demonstrating representative findings, shown in the original slit-lamp image (right) and corresponding heat map for target areas (left).
FIGURE 4The heat maps of the SET-ResNext50 model in slit-lamp image with non-Fuchs uveitis syndrome demonstrating representative findings, shown in the original slit-lamp image (right) and corresponding heat map for target areas (left).